SCD inhibition has been targeted at epithelial ovarian cancer (EOC) to significantly reduce the proliferation of EOC cells and patient-derived organoids and induced apoptotic cell death, while not affecting the non-cancer cells [31]. The gene discussed is SCD; the disease is cancer.